Sumitomo Mitsui Trust Group Inc. Acquires 93,989 Shares of GE HealthCare Technologies Inc. $GEHC

Sumitomo Mitsui Trust Group Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,202,397 shares of the company’s stock after buying an additional 93,989 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.26% of GE HealthCare Technologies worth $89,062,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. Hotchkis & Wiley Capital Management LLC increased its position in GE HealthCare Technologies by 3.2% in the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock worth $464,226,000 after buying an additional 176,572 shares during the period. JPMorgan Chase & Co. increased its position in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares during the period. Dimensional Fund Advisors LP increased its position in shares of GE HealthCare Technologies by 3.3% during the first quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock valued at $398,975,000 after purchasing an additional 157,839 shares during the period. Canada Pension Plan Investment Board increased its position in shares of GE HealthCare Technologies by 15.2% during the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after purchasing an additional 409,636 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in shares of GE HealthCare Technologies by 3.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock valued at $247,708,000 after purchasing an additional 109,858 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $78.14 on Monday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The stock has a market capitalization of $35.68 billion, a price-to-earnings ratio of 16.01, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13. The business’s fifty day moving average price is $74.78 and its two-hundred day moving average price is $72.58. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business’s revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.87%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Barclays assumed coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective on the stock. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Finally, Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a research report on Thursday, September 18th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $85.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.